Medpace Holdings, Inc. Selling, General and Administrative Expense
Medpace Holdings, Inc. (MEDP) reported Selling, General and Administrative Expense of $48.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-23
- Medpace Holdings, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $48.10M, a 3.08% increase year-over-year.
- Medpace Holdings, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $47.92M, a 17.24% decline year-over-year.
- Medpace Holdings, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $44.92M, a 1.14% decline year-over-year.
- Medpace Holdings, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $48.08M, a 2.31% decline year-over-year.
- Medpace Holdings, Inc. selling, general and administrative expense for fiscal 2025 was $197.56M, a 9.64% increase from fiscal 2024.
- Medpace Holdings, Inc. selling, general and administrative expense for fiscal 2024 was $180.18M, a 11.67% increase from fiscal 2023.
- Medpace Holdings, Inc. selling, general and administrative expense for fiscal 2023 was $161.35M, a 22.79% increase from fiscal 2022.
- Medpace Holdings, Inc. selling, general and administrative expense for fiscal 2022 was $131.40M, a 21.19% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $48.10M 10-Q · filed 2026-07-23 | $96.02M 10-Q · filed 2026-07-23 | $140.94M derived: sum of 3 quarters · filed 2026-07-23 | $189.02M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $47.92M 10-Q · filed 2026-04-23 | $92.83M derived: sum of 2 quarters · filed 2026-04-23 | $140.91M derived: sum of 3 quarters · filed 2026-04-23 | $187.58M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $44.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $93.00M derived: sum of 2 quarters · filed 2026-02-10 | $139.66M derived: sum of 3 quarters · filed 2026-07-23 | $197.56M 10-K · filed 2026-02-10 |
| 2025-09-30 | $48.08M 10-Q · filed 2025-10-23 | $94.75M derived: sum of 2 quarters · filed 2026-07-23 | $152.64M 10-Q · filed 2025-10-23 | $198.08M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $46.66M 10-Q · filed 2026-07-23 | $104.56M 10-Q · filed 2026-07-23 | $149.99M derived: sum of 3 quarters · filed 2026-07-23 | $199.21M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $57.90M 10-Q · filed 2026-04-23 | $103.33M derived: sum of 2 quarters · filed 2026-04-23 | $152.55M derived: sum of 3 quarters · filed 2026-04-23 | $194.00M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | $45.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $94.65M derived: sum of 2 quarters · filed 2026-02-10 | $136.10M derived: sum of 3 quarters · filed 2026-02-10 | $180.18M 10-K · filed 2026-02-10 |
| 2024-09-30 | $49.22M 10-Q · filed 2025-10-23 | $90.67M derived: sum of 2 quarters · filed 2025-10-23 | $134.75M 10-Q · filed 2025-10-23 | $177.26M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $41.45M 10-Q · filed 2025-07-22 | $85.53M 10-Q · filed 2025-07-22 | $128.05M derived: sum of 3 quarters · filed 2026-02-10 | $169.46M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $44.08M 10-Q · filed 2025-04-22 | $86.59M derived: sum of 2 quarters · filed 2026-02-10 | $128.00M derived: sum of 3 quarters · filed 2026-02-10 | $167.41M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $42.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $83.92M derived: sum of 2 quarters · filed 2026-02-10 | $123.33M derived: sum of 3 quarters · filed 2026-02-10 | $161.35M 10-K · filed 2026-02-10 |
| 2023-09-30 | $41.41M 10-Q · filed 2024-10-22 | $80.81M derived: sum of 2 quarters · filed 2024-10-22 | $118.84M 10-Q · filed 2024-10-22 | $152.24M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | $39.40M 10-Q · filed 2024-07-23 | $77.43M 10-Q · filed 2024-07-23 | $110.83M derived: sum of 3 quarters · filed 2025-02-11 | $146.25M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | $38.03M 10-Q · filed 2024-04-23 | $71.43M derived: sum of 2 quarters · filed 2025-02-11 | $106.85M derived: sum of 3 quarters · filed 2025-02-11 | $140.06M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | $33.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $68.82M derived: sum of 2 quarters · filed 2025-02-11 | $102.03M derived: sum of 3 quarters · filed 2025-02-11 | $131.40M 10-K · filed 2025-02-11 |
| 2022-09-30 | $35.42M 10-Q · filed 2023-10-24 | $68.63M derived: sum of 2 quarters · filed 2023-10-24 | $98.00M 10-Q · filed 2023-10-24 | $125.66M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $33.22M 10-Q · filed 2023-07-25 | $62.58M 10-Q · filed 2023-07-25 | $90.25M derived: sum of 3 quarters · filed 2024-02-13 | $118.29M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $29.37M 10-Q · filed 2023-04-25 | $57.03M derived: sum of 2 quarters · filed 2024-02-13 | $85.08M derived: sum of 3 quarters · filed 2024-02-13 | $112.05M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $27.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $55.71M derived: sum of 2 quarters · filed 2024-02-13 | $82.68M derived: sum of 3 quarters · filed 2024-02-13 | $108.42M 10-K · filed 2024-02-13 |
| 2021-09-30 | $28.05M 10-Q · filed 2022-10-25 | $55.02M derived: sum of 2 quarters · filed 2022-10-25 | $80.76M 10-Q · filed 2022-10-25 | $103.14M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $26.97M 10-Q · filed 2022-07-26 | $52.71M 10-Q · filed 2022-07-26 | $75.09M derived: sum of 3 quarters · filed 2023-02-14 | $97.89M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $25.74M 10-Q · filed 2022-04-26 | $48.12M derived: sum of 2 quarters · filed 2023-02-14 | $70.92M derived: sum of 3 quarters · filed 2023-02-14 | $92.77M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $22.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $45.18M derived: sum of 2 quarters · filed 2023-02-14 | $67.03M derived: sum of 3 quarters · filed 2023-02-14 | $92.16M 10-K · filed 2023-02-14 |
| 2020-09-30 | $22.80M 10-Q · filed 2021-10-26 | $44.65M derived: sum of 2 quarters · filed 2021-10-26 | $69.78M 10-Q · filed 2021-10-26 | $91.04M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $21.86M 10-Q · filed 2021-07-27 | $46.98M 10-Q · filed 2021-07-27 | $68.24M derived: sum of 3 quarters · filed 2022-02-15 | $97.36M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $25.12M 10-Q · filed 2021-04-27 | $46.38M derived: sum of 2 quarters · filed 2022-02-15 | $75.50M derived: sum of 3 quarters · filed 2022-02-15 | $99.06M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $21.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $50.38M derived: sum of 2 quarters · filed 2022-02-15 | $73.94M derived: sum of 3 quarters · filed 2022-02-15 | $95.25M 10-K · filed 2022-02-15 |
| 2019-09-30 | $29.12M 10-Q · filed 2020-10-27 | $52.68M derived: sum of 2 quarters · filed 2020-10-27 | $73.98M 10-Q · filed 2020-10-27 | $94.55M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $23.56M 10-Q · filed 2020-07-28 | $44.86M 10-Q · filed 2020-07-28 | $65.43M derived: sum of 3 quarters · filed 2021-02-16 | $84.04M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $21.31M 10-Q · filed 2020-04-29 | $41.88M derived: sum of 2 quarters · filed 2021-02-16 | $60.48M derived: sum of 3 quarters · filed 2021-02-16 | $80.99M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $20.57M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $39.17M derived: sum of 2 quarters · filed 2021-02-16 | $59.68M derived: sum of 3 quarters · filed 2021-02-16 | $75.68M 10-K · filed 2021-02-16 |
| 2018-09-30 | $18.61M 10-Q · filed 2019-10-29 | $39.11M derived: sum of 2 quarters · filed 2019-10-29 | $55.11M 10-Q · filed 2019-10-29 | $71.95M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $20.51M 10-Q · filed 2019-07-30 | $36.51M 10-Q · filed 2019-07-30 | $53.35M derived: sum of 3 quarters · filed 2020-02-25 | $69.95M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $16.00M 10-Q · filed 2019-04-30 | $32.84M derived: sum of 2 quarters · filed 2020-02-25 | $49.45M derived: sum of 3 quarters · filed 2020-02-25 | $64.20M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $16.84M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $33.45M derived: sum of 2 quarters · filed 2020-02-25 | $48.20M derived: sum of 3 quarters · filed 2020-02-25 | $63.36M 10-K · filed 2020-02-25 |
| 2017-09-30 | $16.61M 10-Q · filed 2018-10-30 | $31.36M derived: sum of 2 quarters · filed 2018-10-30 | $46.52M 10-Q · filed 2018-10-30 | $63.30M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $14.76M 10-Q · filed 2018-07-31 | $29.91M 10-Q · filed 2018-07-31 | $46.69M derived: sum of 3 quarters · filed 2019-02-26 | $63.08M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $15.15M 10-Q · filed 2018-05-01 | $31.94M derived: sum of 2 quarters · filed 2019-02-26 | $48.33M derived: sum of 3 quarters · filed 2019-02-26 | $63.15M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $16.78M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $33.17M derived: sum of 2 quarters · filed 2019-02-26 | $48.00M derived: sum of 3 quarters · filed 2019-02-26 | $61.51M 10-K · filed 2019-02-26 |
| 2016-09-30 | $16.39M 10-Q · filed 2017-10-31 | $31.21M derived: sum of 2 quarters · filed 2017-10-31 | $44.72M 10-Q · filed 2017-10-31 | $62.98M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $14.82M 10-Q · filed 2017-08-01 | $28.33M 10-Q · filed 2017-08-01 | $46.59M derived: sum of 3 quarters · filed 2018-02-27 | $61.88M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $13.51M 10-Q · filed 2017-05-02 | $31.76M derived: sum of 2 quarters · filed 2018-02-27 | $47.06M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2015-12-31 | $18.25M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $33.55M derived: sum of 2 quarters · filed 2018-02-27 | $57.00M 10-K · filed 2018-02-27 | |
| 2015-09-30 | $15.29M 10-Q · filed 2016-11-03 | $38.74M 10-Q · filed 2016-11-03 | ||
| 2014-12-31 | $29.46M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |